These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16549462)

  • 21. Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats.
    Smit MJ; Temmerman AM; Wolters H; Kuipers F; Beynen AC; Vonk RJ
    J Clin Invest; 1991 Sep; 88(3):943-51. PubMed ID: 1885779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study.
    Nakamura A; Kagaya Y; Saito H; Kanazawa M; Sato K; Miura M; Kondo M; Endo H
    J Atheroscler Thromb; 2023 May; 30(5):443-454. PubMed ID: 35768226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
    Salen G; Shefer S; Tint GS; Nicolau G; Dayal B; Batta AK
    J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects.
    Einarsson C; Hillebrant CG; Axelson M
    Hepatology; 2001 May; 33(5):1189-93. PubMed ID: 11343248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
    de Man FH; de Beer F; van der Laarse A; Jansen H; Leuven JA; Souverijn JH; Vroom TF; Schoormans SC; Fruchart JC; Havekes LM; Smelt AH
    Atherosclerosis; 2000 Dec; 153(2):363-71. PubMed ID: 11164425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents.
    Gidding SS; Prospero C; Hossain J; Zappalla F; Balagopal PB; Falkner B; Kwiterovich P
    J Pediatr; 2014 Sep; 165(3):497-503.e2. PubMed ID: 25008950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy.
    Jonkers IJ; de Man FH; van Tilburg NH; van der Laarse A; Sandset PM; Smelt AH; Bertina RM
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):705-12. PubMed ID: 11734672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia.
    Angelin B; Hershon KS; Brunzell JD
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5434-8. PubMed ID: 3474660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients.
    Hau MF; Smelt AH; Bindels AJ; Sijbrands EJ; Van der Laarse A; Onkenhout W; van Duyvenvoorde W; Princen HM
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1197-202. PubMed ID: 8792775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudy.
    Haim M; Benderly M; Boyko V; Goldenberg I; Tanne D; Battler A; Goldbourt U; Behar S;
    Coron Artery Dis; 2006 Aug; 17(5):455-61. PubMed ID: 16845254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
    Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels.
    Spieker LE; Noll G; Hannak M; Lüscher TF
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):361-5. PubMed ID: 10710119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients.
    Roglans N; Vázquez-Carrera M; Alegret M; Novell F; Zambón D; Ros E; Laguna JC; Sánchez RM
    Eur J Clin Pharmacol; 2004 Feb; 59(12):855-61. PubMed ID: 14685799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
    Arbel Y; Klempfner R; Erez A; Goldenberg I; Benzekry S; Shlomo N; Fisman EZ; Tenenbaum A;
    Cardiovasc Diabetol; 2016 Jan; 15():11. PubMed ID: 26794137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
    Carulli N; Ponz De Leon M; Zironi F; Pinetti A; Smerieri A; Iori R; Loria P
    J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Portal venous bile acids in cholesterol gallstone disease: effect of treatment with chenodeoxycholic and cholic acids.
    Einarsson K; Ahlberg J; Angelin B; Björkhem I; Ewerth S
    Hepatology; 1985; 5(4):661-5. PubMed ID: 4018738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.
    Annuzzi G; Rivellese A; Capaldo B; Di Marino L; Iovine C; Marotta G; Riccardi G
    Atherosclerosis; 1991 Mar; 87(1):65-73. PubMed ID: 1872925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal bile acid absorption in familial hypertriglyceridemia.
    Duane WC
    J Lipid Res; 1995 Jan; 36(1):96-107. PubMed ID: 7706952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study.
    Ohno Y; Miyoshi T; Noda Y; Oe H; Toh N; Nakamura K; Kohno K; Morita H; Ito H
    Cardiovasc Diabetol; 2014 Apr; 13():71. PubMed ID: 24708775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.